Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward, bfsingle
Search This Board:
Last Post: 7/24/2014 7:38:04 PM - Followers: 267 - Board type: Free - Posts Today: 0
NYSE now, upgraded from OTC!                                 

 As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. 

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit http://www.organovo.com

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 07/24/2014 08:06:35 AM
ONVO News: Additional Proxy Soliciting Materials (definitive) (defa14a) 07/11/2014 04:21:04 PM
ONVO News: Proxy Statement (definitive) (def 14a) 07/11/2014 04:17:07 PM
ONVO News: Current Report Filing (8-k) 06/26/2014 08:06:02 AM
ONVO News: Confidential Treatment Order (ct Order) 06/12/2014 09:02:41 AM
News News Alert: Current Report Filing (8-k) 07/24/2014 08:06:35 AM
#6303  Sticky Note 3D BioPrinter ==='s Print a kidney! Big_Money_Upward 06/27/14 12:54:46 PM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#6503   It's all part of the plan, and how rayank 07/24/14 07:38:04 PM
#6502   Good day, but could have been a great day. rayank 07/24/14 07:35:09 PM
#6501   Well if you put it that way then girlfriend 07/24/14 04:58:31 PM
#6500   and Johnson and Johnson just told that short dshade 07/24/14 04:55:10 PM
#6499   oh ok, when some guy named pearson continued 2014trader 07/24/14 04:51:11 PM
#6498   when they announce first liver printing. $125 easy dshade 07/24/14 04:39:48 PM
#6497   125.. Pretty random number, 5-10 years I'll give squashjohn 07/24/14 04:28:47 PM
#6496   always adding here. $125 in a few years! dshade 07/24/14 03:51:55 PM
#6495   Gonna need a reversal of the late day grantg2 07/24/14 03:13:16 PM
#6494   It always saddens me to see some small grantg2 07/24/14 02:48:36 PM
#6493   I'm expecting a climb at the end of HennHouse 07/24/14 02:31:35 PM
#6492   Agree there….anyways…..I am trading ONVO and holding a girlfriend 07/24/14 02:08:49 PM
#6491   MOASS coming on this soon. dshade 07/24/14 01:59:24 PM
#6490   agreed, only naked offshore shorts are crooks. plenty dshade 07/24/14 01:59:04 PM
#6489   so true, giving the shorts another opportunity, 2014trader 07/24/14 01:56:15 PM
#6488   I don't think shorts are "criminals." Thats girlfriend 07/24/14 01:52:11 PM
#6487   only stopped moving up 2wks ago because Fed nonsense dshade 07/24/14 01:45:20 PM
#6486   just the criminals (shorts) doing the only thing 2014trader 07/24/14 01:43:58 PM
#6485   Nothing wrong with taking profits…..good luck to you girlfriend 07/24/14 01:41:56 PM
#6484   will consolidate and continue much higher dshade 07/24/14 01:35:55 PM
#6483   Chart is rebuilding nicely Mr. short dshade 07/24/14 01:26:52 PM
#6482   I fully can relate to your feelings about RandolRocketman 07/24/14 01:26:32 PM
#6481   bought at 8.23..... The drop in price has HennHouse 07/24/14 01:26:09 PM
#6480   How can you be positive? Look at the_chart! rumper 07/24/14 01:05:18 PM
#6479   Only based on posts, I don't get the RallyTheMarket 07/24/14 12:31:00 PM
#6478   I will never fully understand that mentality. I HennHouse 07/24/14 12:24:22 PM
#6477   So what were you in for? Bad news? RallyTheMarket 07/24/14 12:21:06 PM
#6476   adios. some sell news. time to add the rumor dshade 07/24/14 12:12:41 PM
#6475   Good News punishes this stock. I'm out. GLTA rumper 07/24/14 11:56:57 AM
#6474   Organovo News Just published: rookiecrd1 07/24/14 11:09:11 AM
#6473   July 24, 2014, Organovo Holdings, Inc. (the “Company”) dshade 07/24/14 10:55:12 AM
#6472   ONVO----GLTA! dadx4 07/24/14 09:31:35 AM
#6471   Congratulations, longs. Good chance we see a squeeze, chef911 07/24/14 09:21:16 AM
#6470   Up 17% pre market on news: http://biz.yahoo.com/e/140724/onvo8-k.html rayank 07/24/14 09:19:45 AM
#6469   many more major pharma partnerships to come. dshade 07/24/14 09:11:39 AM
#6468   Great news here today. J&J$$$. jjh573 07/24/14 08:33:41 AM
#6467   long and strong. dshade 07/24/14 08:24:31 AM
#6466   Oops.. Reminds me of the guy from 127 squashjohn 07/24/14 08:16:28 AM
#6465   More good news: 72vett 07/24/14 08:16:24 AM
#6464   held up on light volume. impressive Big_Money_Upward 07/23/14 09:28:41 PM
#6463   I agree. I'm against a buy-out at this RallyTheMarket 07/23/14 01:01:05 PM
#6462   true enough. could be $125 when making real dshade 07/23/14 12:55:52 PM
#6461   i want more, i want to see this Big_Money_Upward 07/23/14 12:54:46 PM
#6460   depends. $25/30 plus and shares in a big dshade 07/23/14 12:08:38 PM
#6459   That would be very unfortunate for those of 72vett 07/23/14 12:06:59 PM
#6458   he missed the launch is ahead of Dec dshade 07/23/14 08:45:26 AM
#6457   SA article http://seekingalpha.com/article/2332515-long-on-organovo-artificial-t Big_Money_Upward 07/23/14 08:33:54 AM
#6456   ONVO article: http://seekingalpha.com/article/2332515-long-on-organovo rayank 07/23/14 08:17:43 AM
#6455   bought out. means we make more money if dshade 07/23/14 08:13:11 AM
#6454   What does "taken out" mean? And what would 72vett 07/23/14 07:58:05 AM